ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988